pCDH-UbC-MCS-IRES-GFP Cloning and Expression Lentivector

pCDH-MSCV-MCS-EF1α-Puro Cloning and Expression Lentivector

pCDH-MSCV-MCS-EF1α-GFP Cloning and Expression Lentivector

pCDH-MSCV-MCS-EF1α-GFP+Puro Cloning and Expression Lentivector

pCDH-MSCV-MCS-IRES-GFP Cloning and Expression Lentivector

pCDH-EF1α-MCS-(PGK-Puro) Bidirectional Promoter Cloning and Expression Lentivector

pCDH-EF1α-MCS-(PGK-GFP) Bidirectional Promoter Cloning and Expression Lentivector

pCDH-EF1α-MCS-(PGK-GFP-T2A-Puro) Bidirectional Promoter Cloning and Expression Lentivector

pCDH-EF1α-MCS-T2A-RFP (PGK-Puro) Bidirectional Promoter Cloning and Expression Lentivector

pCDH-EF1α-MCS-T2A-GFP (PGK-Puro) Bidirectional Promoter Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-RFP Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-GreenPuro Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-Neo Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-Hygro Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-RFP+Puro Cloning and Expression Lentivector

pCDH-MCS-T2A-Puro-MSCV Cloning and Expression Lentivector

pCDH-MCS-T2A-copGFP-MSCV Cloning and Expression Lentivector

pCDH-CMV-MCS-T2A-copGFP Cloning and Expression Lentivector

pCDH-EF1α-MCS*-T2A-GFP Cloning and Expression Lentivector

pCDH-EF1α-MCS-T2A-Puro Cloning and Expression Lentivector

pCDH-EF1α-MCS-IRES-GFP Cloning and Expression Lentivector

pCDH-EF1α-MCS-IRES-RFP Cloning and Expression Lentivector

pCDH-EF1α-MCS-IRES-Puro Cloning and Expression Lentivector

pCDH-EF1α-MCS-IRES-Neo Cloning and Expression Lentivector

pCDH-EF1α-MCS-BGH-PGK-GFP-T2A-Puro Cloning and Expression Lentivector

pCDH-UbC-MCS-EF1α-Hygro Cloning and Expression Lentivector

pCDH-CMV-MCS Cloning and Expression Lentivector

pCDH-CMV-MCS2 Cloning and Expression Lentivector

pCDH-EF1α-MCS Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-Puro Cloning and Expression Lentivector

pCDH-CMV-MCS-EF1α-copGFP Cloning and Expression Lentivector

  • Soong, RS, et al. (2014) Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors. PLoS ONE. 2014 Mar 25; 9(3):e93162. PM ID: 24664420